Difference between revisions of "Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substrates. - PubMed - NCBI"
From Fiamma
Jump to navigationJump to search (Created page with "{{B| https://www.ncbi.nlm.nih.gov/pubmed/28054436 |Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substra...") |
|||
| Line 13: | Line 13: | ||
[[Category: Productivity]] | [[Category: Productivity]] | ||
[[Category: Studies]] | [[Category: Studies]] | ||
| + | [[Category: Melancholy]] | ||
A total of 95 male inpatients were assigned to three groups and were asked to take either '''caffeine (60, 120mg)''' or placebo (soymilk powder) daily for 4 weeks on the basis of their current antidepressant medications. Results showed that chronic supplementation with low dose of caffeine '''(60 mg) produced rapid antidepressant action''' by reduction of depressive scores. Furthermore, low dose of caffeine '''improved cognitive performance in depressed patients'''. | A total of 95 male inpatients were assigned to three groups and were asked to take either '''caffeine (60, 120mg)''' or placebo (soymilk powder) daily for 4 weeks on the basis of their current antidepressant medications. Results showed that chronic supplementation with low dose of caffeine '''(60 mg) produced rapid antidepressant action''' by reduction of depressive scores. Furthermore, low dose of caffeine '''improved cognitive performance in depressed patients'''. | ||
Revision as of 13:35, 9 January 2017
https://www.ncbi.nlm.nih.gov/pubmed/28054436
Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substrates. - PubMed - NCBI
A total of 95 male inpatients were assigned to three groups and were asked to take either caffeine (60, 120mg) or placebo (soymilk powder) daily for 4 weeks on the basis of their current antidepressant medications. Results showed that chronic supplementation with low dose of caffeine (60 mg) produced rapid antidepressant action by reduction of depressive scores. Furthermore, low dose of caffeine improved cognitive performance in depressed patients.
